Fulgent Genetics (FLGT) Research & Development (2015 - 2026)

Fulgent Genetics (FLGT) has 12 years of Research & Development data on file, last reported at $14.2 million in Q1 2026.

• Quarterly Research & Development rose 14.37% year-over-year to $14.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.7 million (up 11.87% YoY) and the FY2025 annual result came in at $53.9 million, up 10.42% from the prior year.
• Research & Development was little changed at $14.2 million in Q1 2026 per FLGT's latest filing, from $14.2 million in the prior quarter.
• The five-year high for Research & Development was $14.2 million in Q1 2026, with the low at $6.0 million in Q1 2022.
• Average Research & Development over 5 years is $11.0 million, with a median of $11.8 million recorded in 2024.
• Year-over-year, Research & Development jumped 63.33% in 2023 and fell 0.04% in 2025.
• Fulgent Genetics' Research & Development stood at $8.5 million in 2022, then soared by 40.46% to $12.0 million in 2023, then rose by 1.35% to $12.1 million in 2024, then climbed by 16.98% to $14.2 million in 2025, then climbed by 0.04% to $14.2 million in 2026.
• Business Quant data shows FLGT's Research & Development at $14.2 million in Q1 2026, $14.2 million in Q4 2025, and $13.9 million in Q3 2025.